A pharmaceutical scientist with expertise in medicinal chemistry, drug design, pharmaceutics, and neurotherapeutic research. Research experience includes the design, synthesis, and biological evaluation of small molecules targeting neuroinflammation, Alzheimer’s disease, and glioblastoma. Technical expertise includes structure–activity relationship analysis, molecular docking, ADMET prediction, in vitro pharmacological evaluation, flow cytometry, Western blotting, qPCR, ELISA, and cell-based assays. Broader research interests include neurodegenerative diseases, neuroinflammation, targeted protein degradation, artificial intelligence in drug discovery, drug metabolism, and translational pharmaceutical research. Active contributions to scientific publishing include peer-reviewed research articles, review publications, and manuscript reviewing for journals in pharmaceutical sciences, medicinal chemistry, neuroscience, and drug discovery.